The De Novo classification pathway offers a regulatory route for novel medical devices that do not have a predicate in the US market. This white paper provides an in-depth overview of the De Novo submission process, outlining the key steps, documentation requirements, considerations, and challenges faced by manufacturers seeking to obtain FDA clearance through this pathway.